-
Most Recent
Search Results
240 results for BCR
Before Luke Lango Recommends Any Private Company, It Has to Pass This Test
In today’s Friday Digest takeover, Luke Lango shares the three-part framework he uses to evaluate private companies before they ever reach Wall Street. He explains…
How Venture Capitalists Really Decide Where to Invest
After years of studying history’s greatest venture capital successes, my InvestorPlace colleague Luke Lango has developed a straightforward process for identifying exceptional companies.
Make Biogen Inc (BIIB) Stock Pay You, Even With No Dividend
The best way to trade volatile stocks like Biogen (BIIB) is to leave room for error. We can do this with BIIB stock while generating…
CR Bard, Caterpillar Keep S&P 500 Flat
Caterpillar and CR Bard stocks fall after disappointing earnings; S&P 500 shaves off just a few points.
Most Startup Pitches Sound Great, so Here’s How to Find the Real Opportunities
Over years of studying some of history’s greatest venture capital successes, Luke Lango has developed a straightforward framework for evaluating young companies before they ever…
5 More Under-the-Radar Dividend Divas
These stocks don’t all offer the most glamorous payouts, but they’ve delivered consistent, increasing dividends for years, and have potential for capital gains.
Follow the Smoothie, Not the Beer
Gen Z wellness spending is shifting dollars from bars and beer to fitness, recovery, and functional drinks – creating a new stock trade.
5 Companies That Increased Dividends Last Week
Dividend increases have been in short supply for the past few weeks, but industrial, retail and transportation giants top the short list.
The Day Wall Street Opened the Door to an Industry That Barely Existed
Genentech’s early IPO shows why today’s biggest AI gains may be created before a company ever reaches the stock market.
Stock Upgrades: COST, LLY, RDS, WMT
Costco (COST), Eli Lilly (LLY), Royal Dutch Shell (RDS) and Walmart (WMT) were among some of the widely held stocks upgraded by Louis Navellier in…
BPTH Stock: Why Bio-Path Holdings Is Skyrocketing 200% Today
Bio-Path Holdings (BPTH) stock is rocketing higher on Wednesday after announcing patent updates for its DNAbilize platform.
Healthcare Stocks Are Tempting, But Don’t Buy Just Yet
Healthcare stocks have dipped lower for the past month, which might seem like a buying opportunity. But long-term investors should wait for a better bargain.
Downgrades This Week – COST, XOM, MS
Costco (COST), Exxon Mobil (XOM) and Morgan Stanley (MS) were among some of the widely held stocks downgraded by Louis Navellier in his latest fundamental…
High Yield Dividend Stocks – 8 Picks Boosting Dividends Now
For dividend stock investors looking for regular paydays to add to their retirement funds, things have finally started to look up in 2010. High yield…
7 Rewarding Dividend Growth Stocks
Are these the perfect dividend growth stocks? They pay above average yields and consistently grow distributions at least once per year.
8 Companies Increasing Dividends
This week’s list of payout-boosting performers include big names like Caterpillar, Target and United Technologies.
Bio-Path Holdings News: Why BPTH Stock Is Soaring Today
BPTH stock received a boost on Thursday after Bio-Path received a notice of allowance for a strategic patent for its candidate Prexigebersen.
How High Will This Market Go?
The major indices’ next resistance zones are the targets for the current advance.
Buy ‘Aristocrat’ Funds for the Quality, Not the Dividend Yield
Dividend funds centered around serial payout improvers are about harnessing quality, not headline dividend yield.
77 Ways to Zig While the Market is Zagging
Take a look at this stock screen for a look at our new moves for 77 stocks rated by Portfolio Grader.
Stock Downgrades: GOOG, LMT, SNE
Google (GOOG), Lockheed Martin (LMT) and Sony (SNE) were among some of the widely held stocks downgraded by Louis Navellier in his latest fundamental stock…
6 – 10 of 240 results